参考文献/References:
[1] Weissleder R.Molecular imaging:exploring the next frontier.Radiology,1999,212(3):609-614.
[2] Weissleder R,Mahmood U.Molecular imaging.Radiology,2001,219(2):316-333.
[3] Blasberg RG,Tjuvajev JG.Molecular-genetic imaging:current and future perspectives.J Clin Invest,2003,111(11):1620-1629.
[4] Khalil MM,Tremoleda JL,Bayomy TB,et al.Molecular SPECT Imaging:An Overview[J/OL].Int J Mol Imaging,2011,2011:796025.[2011-07-24].http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094893/.
[5] Young KJ,Jun OS,Sook RJ,et al.Synthesis of 99mTc(CO)3-deoxyuridine derivatives as potential HSV1-tk gene expression imag-ing agents.Appl Radiat Isot,2008,66(4):489-496.
[6] Chin FT,Namavari M,Levi J,et al.Semiautomated radiosynthesis and biological evaluation of [18F] FEAU:a novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression.Mol Imaging Biol,2008,10(2):82-91.
[7] Cai H,Yin D,Zhang L,et al.Preparation and biological evaluation of 2-amino-6-[18F] fluoro-9-(4-hydroxy-3-hydroxy-methylbutyl) purine(6-[18F]FPCV) as a novel PET probe for imaging HSV1-tk reporter gene expression.Nucl Med Biol,2007,34(6):717-725.
[8] Cho SY,Havasi L,Szajek LP,et al.Evaluation of 76Br-FBAU as a PET reporter probe for HSV1-tk gene expression imaging using mouse models of human glioma.J Nucl Med,2005,46(11):1923-1930.
[9] Alauddin MM,Shahinian A,Gordon EM,et al.Direct comparison of radiolabeled probes FMAU,FHBG,and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model.Mol Imaging,2004,3(2):76-84.
[10] Liang Q,Gotts J,Satyamurthy N,et al.Noninvasive,repetitive,quantitative measurement of gene expression from a bicistronic message by positron emission tomography,following gene transfer with adenovirus.Mol Ther,2002,6(1):73-82.
[11] Vadysirisack DD,Shen DH,Jhiang SM.Correlation of Na+/I- symporter expression and activity:implications of Na+/I- symporter as an imaging reporter gene.J Nucl Med,2006,47(1):182-190.
[12] Anton M,Wagner B,Haubner R,et al.Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells.J Gene Med,2004,6(1):119-126.
[13] Lewis MR.A "new" reporter in the field of imaging reporter genes:correlating gene expression and function of the sodium/iodide symporter.J Nucl Med,2006,47(1):1-3.
[14] Bogdanov A Jr,Petherick P,Marecos E,et al.In vivo localization of diglycylcysteine-bearing synthetic peptides by nuclear imaging of oxotechnetate transchelation.Nucl Med Biol,1997,24(8):739-742.
[15] Northrop JP,Bednarski M,Barbieri SO,et al.Cell surface expression of single chain antibodies with applications to imaging of gene expression in vivo.Eur J Nucl Med Mol Imaging,2003,30(9):1292-1298.
[16] Pfannenberg C,Aschoff P,Dittmann H,et al.PET/CT with 18F-FLT:does it improve the therapeutic management of metastatic germ cell tumors?.J Nucl Med,2010,51(6):845-853.
[17] Smith RA,Guleryuz S,Manning HC.Molecular imaging metrics to evaluate response to preclinical therapeutic regimens.Front Biosci,2011,16:393-410.
[18] Vande VG,Baekelandt V,Dresselaers T,et al.Magnetic resonance imaging and spectroscopy methods for molecular imaging.Q J Nucl Med Mol Imaging,2009,53(6):565-585.
[19] Lecchi M,Ottobrini L,Martelli C,et al.Instrumentation and probes for molecular and cellular imaging.Q J Nucl Med Mol Imaging,2007,51(2):111-126.
[20] Ye F,Wu X,Jeong EK,et al.A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI.Bioconjug Chem,2008,19(12):2300-2303.
[21] Hengerer A,Grimm J.Molecular magnetic resonance imaging [J/OL].Biomed Imaging Interv J,2006,2(2):e8.[2011-07-24].http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097616/.
[22] Liu W,Dahnke H,Rahmer J,et al.Ultrashort T2* relaxometry for quantitation of highly concentrated superparamagnetic iron oxide(SPIO) nanoparticle labeled cells.Magn Reson Med,2009,61(4):761-766.
[23] Daldrup-Link HE,Brasch RC.Macromolecular contrast agents for MR mammography:current status.Eur Radiol,2003,13(2):354-365.
[24] Glunde K,Artemov D,Penet MF,et al.Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer.Chem Rev,2010,110(5):3043-3059.
[25] Kiessling F,Gaetjens J,Palmowski M.Application of molecular ultrasound for imaging integrin expression.Theranostics,2011,1:127-134.
[26] Deshpande N,Needles A,Willmann JK.Molecular ultrasound imaging:current status and future directions.Clin Radiol,2010,65(7):567-581.
[27] Anderson CR,Hu X,Zhang H,et al.Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.Invest Radiol,2011,46(4):215-224.
[28] Gessner R,Dayton PA.Advances in molecular imaging with ultrasound.Mol Imaging,2010,9(3):117-127.
[29] Voigt JU.Ultrasound molecular imaging.Methods,2009,48(2):92-97.
[30] Ntziachristos V,Bremer C,Weissleder R.Fluorescence imaging with near-infrared light:new technological advances that enable in vivo molecular imaging.Eur Radiol,2003,13(1):195-208.
[31] Hilderbrand SA,Weissleder R.Near-infrared fluorescence:application to in vivo molecular imaging.Curr Opin Chem Biol,2010,14(1):71-79.
[32] Qin C,Zhu S,Tian J.New optical molecular imaging systems.Curr Pharm Biotechnol,2010,11(6):620-627.
[33] Popovtzer R,Agrawal A,Kotov NA,et al.Targeted gold nanoparticles enable molecular CT imaging of cancer.Nano Lett,2008,8(12):4593-4596.
[34] Wyss C,Schaefer SC,Juillerat-Jeanneret L,et al.Molecular imaging by micro-CT:specific E-selectin imaging.Eur Radiol,2009,19(10):2487-2494.
[35] Montet X,Pastor CM,Vallee JP,et al.Improved visualization of vessels and hepatic tumors by micro-computed tomography(CT) using iodinated liposomes.Invest Radiol,2007,42(9):652-658.
[36] Pan D,Roessl E,Schlomka JP,et al.Computed tomography in color:NanoK-enhanced spectral CT molecular imaging.Angew Chem Int Ed Engl,2010,49(50):9635-9639.
[37] Lucignani G.PET-MRI synergy in molecular,functional and anatomical cancer imaging.Eur J Nucl Med Mol Imaging,2008,35(8):1550-1553.
[38] Schiepers C,Dahlbom M.Molecular imaging in oncology:the aceptance of PET/CT and the emergence of MR/PET imaging.Eur Radiol,2011,21(3):548-554.
[39] Sauter AW,Wehrl HF,Kolb A,et al.Combined PET/MRI:one step further in multimodality imaging.Trends Mol Med,2010,16(11):508-515.
相似文献/References:
[1]张晓,兰晓莉,胡帆,等.点击化学在分子影像学中的应用和进展[J].国际放射医学核医学杂志,2016,40(3):196.[doi:10.3760/cma.j.issn.1673-4114.2016.03.008]
Zhang Xiao,Lan Xiaoli,Hu Fan,et al.Applications and advances of click chemistry in molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):196.[doi:10.3760/cma.j.issn.1673-4114.2016.03.008]
[2]解朋,黄建敏,张芳,等.99Tcm-MAG3-isoDGR-2C分子探针的制备与体内分布的实验研究[J].国际放射医学核医学杂志,2016,40(5):345.[doi:10.3760/cma.j.issn.1673-4114.2016.05.004]
Xie Peng,Huang Jianmin,Zhang Fang,et al.Labeling MAG3-isoDGR-2C with 99Tcm and its biodistribution in mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):345.[doi:10.3760/cma.j.issn.1673-4114.2016.05.004]
[3]汪文霞,兰晓莉,张永学.HER2的表达及其分子影像的研究进展[J].国际放射医学核医学杂志,2016,40(5):363.[doi:10.3760/cma.j.issn.1673-4114.2016.05.007]
Wang Wenxia,Lan Xiaoli,Zhang Yongxue.Research and development of HER2 expression molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):363.[doi:10.3760/cma.j.issn.1673-4114.2016.05.007]
[4]安淑娴,宋少莉,黄钢.放射性核素标记的凋亡显像剂的研究进展[J].国际放射医学核医学杂志,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
An Shuxian,Song Shaoli,Huang Gang.Recent advances in apoptosis imaging using radionuclide-labeled tracers[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
[5]李帅,李剑明.动脉粥样硬化易损斑块放射性核素标记分子探针的研究进展[J].国际放射医学核医学杂志,2015,39(1):80.[doi:10.3760/cma.j.issn.1673-4114.2015.01.017]
Li Shuai,Li Jianming.Research progress of molecular probes labeled with radionuclide for imaging of atherosclerosis vulnerable plaque[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):80.[doi:10.3760/cma.j.issn.1673-4114.2015.01.017]
[6]林潇,唐明灯.靶向表皮生长因子受体分子探针研究进展[J].国际放射医学核医学杂志,2015,39(1):85.[doi:10.3760/cma.j.issn.1673-4114.2015.01.018]
Lin Xiao,Tang Mingdeng.Research progresses on molecular probes targeting epidermal growth factor receptor[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):85.[doi:10.3760/cma.j.issn.1673-4114.2015.01.018]
[7]孔艳艳,管一晖,吴平.PET分子探针在阿尔茨海默病早期诊断中的研究进展[J].国际放射医学核医学杂志,2012,36(5):257.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.001]
KONG Yan-yan,GUAN Yi-hui,WU Ping.Novel PET molecular probes for early diagnosis of Alzheimer’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):257.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.001]
[8]吴涛,安锐.分子影像报告基因系统的研究进展[J].国际放射医学核医学杂志,2010,34(4):198.[doi:10.3760/cma.j.issn.1673-4114.2010.04.002]
WU Tao,AN Rui.Advances in study of molecular imaging reporter gene systems[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):198.[doi:10.3760/cma.j.issn.1673-4114.2010.04.002]
[9]曹丰,陈跃.双模式分子影像探针研究进展[J].国际放射医学核医学杂志,2010,34(1):1.[doi:10.3760/cma.j.issn.1673-4114.2010.01.001]
CAO Feng,CHEN Yue.The research progress of dual-modality probes for molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):1.[doi:10.3760/cma.j.issn.1673-4114.2010.01.001]
[10]蔡汉成,尹端沚,张岚,等.早期诊断阿尔茨海默病的PET分子探针[J].国际放射医学核医学杂志,2006,30(4):202.
CAI Han-cheng,YIN Duan-zhi,ZHANG Lan,et al.PET molecular probes for early detection of Alzheimer’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(5):202.